Daniel Bsteh

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “REPROGRAMMING CBX8-PRC1 FUNCTION WITH A POSITIVE ALLOSTERIC MODULATOR”.

REPROGRAMMING CBX8-PRC1 FUNCTION WITH A POSITIVE ALLOSTERIC MODULATOR

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.23.432388

N/A

0.208DataRank · unranked

3 citations

Daniel Bsteh, Yibo Si, Bryce Hart, Tyler Weaver, Carina Pribitzer +22 more

m6A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer

NAR Cancer(2023)10.1093/narcan/zcad054

N/A

0DataRank · unranked

13 citations

Aubree Mades, Lisa Swartz, Maheen Iqbal, Tong Xu, Daniel Bsteh +4 more

Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5080

N/A

0DataRank · unranked

2 citations

Catherine M. Tangen, Melissa Plets, Daniel Bsteh, Tong Xu, Jacek Pinski +13 more

HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5036

N/A

0DataRank · unranked

0 citations

Jonathan D. Buckley, Dejerianne Ostrow, Jean‐Hugues Parmentier, Smruthi Maganti, Scott A. Mitchell +14 more

Combined Transcriptomic and Epitranscriptomic Profiling Identifies THBS1 as A Regulator of Enzalutamide Resistance in Prostate Cancer

Cancer Heterogeneity and Plasticity(2025)10.47248/chp2502020007

N/A

0DataRank · unranked

1 citations

Lisa Swartz, Aubree Mades, Daniel Bsteh, Tong Xu, Suhn K. Rhie +2 more

Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e17111

N/A

0DataRank · unranked

1 citations

Jonathan D. Buckley, Scott A. Mitchell, Dejerianne Ostrow, Jean‐Hugues Parmentier, Samin Maleki Jahan +13 more